November 5, 2018
Pay for delay deals discussed in Supreme Court
Supreme Court justices listened to arguments about the advisability of reverse settlement deals between generic drug makers and the pharmaceutical companies their products often emulate. The U.S. Justice Department claimed that these agreements add to drug company profits at the expense of consumers. The settlements occur when firms that make […]
Read More